Author

I. Malet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

A.-G. Marcelin· 2 shared S. S. Marot· 2 shared V. Calvez· 2 shared A. Jary· 1 shared B. Abdi· 1 shared B. Gaborit· 1 shared B. Vanhove· 1 shared C. Ciron· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A.-G. Marcelin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.

B. Vanhove, S. S. Marot, R. So, B. Gaborit, G. Evanno, I. Malet, G. Lafrogne, E. Mevel, C. Ciron, P.-J. Royer, E. Lheriteau, F. Raffi, R. Bruzzone, C. K. P. Mok, O. Duvaux, , V. Calvez

XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike RBD, neutralizes multiple variants by targeting multiple epitopes and shows potential in clinical trials.

bioRxiv · Apr 2, 2021Immunology

Neutralization heterogeneity of United Kingdom and South-African SARS CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers

S. S. Marot, I. Malet, A. Jary, V. Leducq, B. Abdi, E. Teyssou, C. Soulie, M. Wirden, C. Rodriguez, S. Fourati, J.-M. Pawlotsky, D. Boutolleau, S. Burrel, V. Calvez, A.-G. Marcelin

The study assesses neutralizing antibody potency against UK and SA SARS-CoV-2 variants in vaccinated and convalescent healthcare workers, finding reduced neutralization against SA variants in some convalescents.

bioRxiv · Mar 5, 2021Microbiology